Get Your Free ValuationEBITDA Multiple
To first offer
Buyer Types
Deal-size range
Healthcare M&A in the UAE is not a broker job. It requires understanding DHA and DOH regulatory frameworks, coordinating licence transfers, and positioning the business correctly for healthcare-specific buyers. Dopamine has direct relationships with active healthcare acquirers in the UAE and GCC, and manages the full regulatory coordination process.
What Buyers Look For
Common Deal-Killers
Get Your Free ValuationHealthcare clinics in the UAE typically sell for 4–6x EBITDA. Specialty clinics with strong patient retention and clean DHA/MOH compliance can reach 6–7x. GP clinics with high doctor dependency trade at the lower end.
DHA licence transfers require buyer approval, a change-of-ownership application, and confirmation that all doctors and clinical staff maintain valid DHA/DOH permits. Dopamine coordinates the regulatory process alongside legal counsel.
Yes, but doctor visa dependency significantly affects valuation. Buyers discount heavily for clinics where departure of the founding doctor would cause patient attrition. Dopamine advises on how to structure the transition to protect value.
Patient data transfer must comply with DHA data governance requirements. Patient consent and data security are part of the due diligence process. Dopamine works with legal advisors to ensure compliant data room and transfer.
Buyers include regional healthcare groups, private equity backed platforms, and individual physician investors. Dopamine maintains direct relationships with active healthcare acquirers across the UAE and GCC.